News

New Series Highlights Community Life on REAL Shows Network

New Series Highlights Community Life on REAL Shows Network

New Series Shines a Light on Northern Nevada

REAL Shows Network (RSN) is thrilled to announce the launch of a captivating new series, Selling the 775. This show, poised to elevate the representation of real estate and lifestyle narratives, is hosted by the well-respected local real estate expert, Mary Thomas. The series is produced by RSN’s talented team, known for their Emmy nominations and Telly Awards, ensuring a high-quality viewing experience.

Capturing the Essence of Northern Nevada

Selling the 775 embodies the vibrant culture and personality of Northern Nevada by intertwining real estate insights with local stories. Each episode is crafted to celebrate the neighborhoods, businesses, and individuals that contribute significantly to the area's identity. Mary Thomas takes viewers on a journey through notable locations, underscoring the rich tapestry of community life.

An Authentic Community Platform

This series is not just about real estate; it's about building a brand that resonates with the community. Selling the 775 provides Mary with a full 30 minutes to connect with viewers, making the episodes personality-driven. The show serves as a powerful platform for local organizations, including nonprofits and entrepreneurs, to share their narratives and impact. The lifestyle-centric segments are designed to engage audiences, allowing them to see what makes Northern Nevada unique.

Uplifting Communities Through Storytelling

At the heart of REAL Shows Network's mission is positive, authentic media that fosters community connections. Selling the 775 is committed to highlighting the everyday experiences that make each neighborhood distinctive and extraordinary. This fresh approach to storytelling is aimed at uplifting local businesses, initiatives, and the causes that matter to residents, offering a new perspective and entertaining content.

About REAL Shows Network

REAL Shows Network is not just another TV platform; it is a dedicated medium for real estate experts and local leaders. With a mission to empower hosts in each market, RSN provides them with the opportunity to lead their own 30-minute shows, showcasing their expertise and community connections. Created by an Emmy-nominated, Telly Award-winning production team, RSN focuses on delivering cinematic, lifestyle-oriented stories that enhance community engagement and elevate positivity across regions.

Frequently Asked Questions

What is Selling the 775 about?

Selling the 775 is a new series on REAL Shows Network that explores Northern Nevada's real estate, culture, and community stories, hosted by Mary Thomas.

Who produces Selling the 775?

The show is produced by REAL Shows Network, featuring an Emmy-nominated and Telly Award-winning production team.

How long is each episode of Selling the 775?

Each episode runs for 30 minutes, giving the host ample time to connect with the audience and share community insights.

What is the mission of REAL Shows Network?

RSN aims to empower local hosts by providing a platform for authentic storytelling, focusing on the positive aspects of communities.

Can local businesses participate in the show?

Yes, Selling the 775 highlights local businesses, organizations, and community influencers, providing them a platform to share their stories.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 249

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Bloom Nutrition Unveils Bloom Pop: A Healthier Soda Choice

Updated Category News Views 425

Bloom Nutrition Introduces Bloom Pop Bloom Nutrition, the brand known for revolutionizing the wellness industry, has launched an exciting new product called Bloom Pop. This innovative soda is now available exclusively at Walmart, marking a significant step in the brand's journey towards making healthier options fun and accessible. A Bold and Bubbly Innovation Bloom Pop...

Continue Reading
Renault Surpasses Stellantis in European Car Market Growth

Updated Category News Views 502

Renault's Growth in the European Car Market Recent statistics reveal that new car sales in Europe showed a modest increase of 0.9% in 2024, primarily driven by a significant rise in hybrid vehicle registrations. This surge marks the fourth consecutive month where hybrid sales have surpassed those of petrol vehicles, indicating a pivotal shift in consumer preferences....

Continue Reading
Market Reactions Following Intense Presidential Debate Showdown

Updated Category News Views 91

Markets React to the Presidential Debate U.S. stock futures slipped and the dollar softened as investors watched a heated presidential debate reshape the political conversation. It was the first direct face-off between Republican candidate Donald Trump and Democratic Vice President Kamala Harris. Early reads from traders and analysts suggested Harris may have had the...

Continue Reading
Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in UK

Updated Category News Views 81

Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in the UK Eli Lilly and Company has recently celebrated a significant milestone with the approval of their innovative treatment, Kisunla™ (donanemab-azbt), for mild cognitive impairment and mild dementia associated with Alzheimer's disease. This groundbreaking therapy is specifically designed for adult...

Continue Reading